Validity of an NGS-based multiple gene panel in identifying actionable mutations for patients with NSCLC in a Chinese hospital

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. A number of targeted therapies have been approved for clinical use or are in clinical trials. Next generation sequencing (NGS) is widely applied in the identification of actionable genomic alterations and enables personalized...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Wei, Yan, Chenghai, Wang, Hailong, Tang, Tom, Wang, Haifeng, Liu, Dujuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507321/
https://www.ncbi.nlm.nih.gov/pubmed/31186761
http://dx.doi.org/10.3892/ol.2019.10265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507321/
https://www.ncbi.nlm.nih.gov/pubmed/31186761
http://dx.doi.org/10.3892/ol.2019.10265

Ejemplares similares